Abstract
This study was undertaken to determine whether anti-GM1 titres are raised in polyneuropathies of unknown origin and whether determination of these titres is useful for diagnosing these conditions. The study population comprised 20 controls (aged 36-88 years), 12 patients with polyneuropathies of known origin (aged 31-81 years) and 15 patients with polyneuropathies of unknown origin (aged 40-77 years). Antibody levels were measured using a commercial GM1 enzyme linked immunosorbent assay kit (Buehlmann Laboratories). Mean anti-GM1 IgG and IgM antibody titres were not raised in patients with polyneuropathies of unknown origin. Anti-GM1 IgG antibody titres were raised in one and GM1 IgM antibody titres in none of the patients with polyneuropathies of unknown origin. In conclusion, GM1 antibody levels are rarely raised in polyneuropathies of unknown origin and probably play a minor role in the pathogenesis of these conditions.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bansal A. S., Abdul-Karim B., Malik R. A., Goulding P., Pumphrey R. S., Boulton A. J., Holt P. L., Wilson P. B. IgM ganglioside GM1 antibodies in patients with autoimmune disease or neuropathy, and controls. J Clin Pathol. 1994 Apr;47(4):300–302. doi: 10.1136/jcp.47.4.300. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Corbo M., Quattrini A., Latov N., Hays A. P. Localization of GM1 and Gal(beta 1-3)GalNAc antigenic determinants in peripheral nerve. Neurology. 1993 Apr;43(4):809–814. doi: 10.1212/wnl.43.4.809. [DOI] [PubMed] [Google Scholar]
- Harvey G. K., Toyka K. V., Zielasek J., Kiefer R., Simonis C., Hartung H. P. Failure of anti-GM1 IgG or IgM to induce conduction block following intraneural transfer. Muscle Nerve. 1995 Apr;18(4):388–394. doi: 10.1002/mus.880180404. [DOI] [PubMed] [Google Scholar]
- Kaji R., Hirota N., Oka N., Kohara N., Watanabe T., Nishio T., Kimura J. Anti-GM1 antibodies and impaired blood-nerve barrier may interfere with remyelination in multifocal motor neuropathy. Muscle Nerve. 1994 Jan;17(1):108–110. doi: 10.1002/mus.880170117. [DOI] [PubMed] [Google Scholar]
- Kornberg A. J., Pestronk A., Bieser K., Ho T. W., McKhann G. M., Wu H. S., Jiang Z. The clinical correlates of high-titer IgG anti-GM1 antibodies. Ann Neurol. 1994 Feb;35(2):234–237. doi: 10.1002/ana.410350217. [DOI] [PubMed] [Google Scholar]
- Kornberg A. J., Pestronk A. The clinical and diagnostic role of anti-GM1 antibody testing. Muscle Nerve. 1994 Jan;17(1):100–104. doi: 10.1002/mus.880170115. [DOI] [PubMed] [Google Scholar]
- Pestronk A. Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies. Muscle Nerve. 1991 Oct;14(10):927–936. doi: 10.1002/mus.880141002. [DOI] [PubMed] [Google Scholar]
- Santoro M., Uncini A., Corbo M., Staugaitis S. M., Thomas F. P., Hays A. P., Latov N. Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann Neurol. 1992 Apr;31(4):385–390. doi: 10.1002/ana.410310407. [DOI] [PubMed] [Google Scholar]
- Thomas F. P., Trojaborg W., Nagy C., Santoro M., Sadiq S. A., Latov N., Hays A. P. Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier. Acta Neuropathol. 1991;82(5):378–383. doi: 10.1007/BF00296548. [DOI] [PubMed] [Google Scholar]
- Willison H. J., Chancellor A. M., Paterson G., Veitch J., Singh S., Whitelaw J., Kennedy P. G., Warlow C. P. Antiglycolipid antibodies, immunoglobulins and paraproteins in motor neuron disease: a population based case-control study. J Neurol Sci. 1993 Feb;114(2):209–215. doi: 10.1016/0022-510x(93)90300-n. [DOI] [PubMed] [Google Scholar]
- Willison H. J., Paterson G., Kennedy P. G., Veitch J. Cloning of human anti-GM1 antibodies from motor neuropathy patients. Ann Neurol. 1994 Apr;35(4):471–478. doi: 10.1002/ana.410350416. [DOI] [PubMed] [Google Scholar]